AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 788694
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no prostaglandin treatment)
Trial: 28693558
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of elemental zinc orally for 14 days
Trial: 25182142
Drug: 28 g
RxNorm normalized name: SM Syringe 28 g, 0.5cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 28 g almonds
Trial: 25182142
Drug: 42 g
RxNorm normalized name: PETROLATUM 42 g in 100 g TOPICAL OINTMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 42 g almonds
Trial: 25182142
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 g almonds)
Trial: 21435092
Drug: 14-day hybrid
RxNorm normalized name: Ricinus hybridus oil
DrugBank: Castor oil (DB11113)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-day hybrid therapy (esomeprazole and amoxicillin for 7 days followed by esomeprazole, amoxicillin, clarithromycin, and metronidazole for 7 days)
Trial: 6606421
Drug: Single 1.92g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 1.92g dose of co-trimoxazole
Trial: 23423302
Drug: L-arginine (ARG)
DrugBank: L-arginine (DB17289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (ARG) 6 g
Trial: 23423302
Drug: L-arginine (ARG)
DrugBank: L-arginine (DB17289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (ARG) 6 g plus 25 g carbohydrate (ARG + CHO)
Trial: 20872778
Drug: SB-742457 35
RxNorm normalized name: SB-649868
DrugBank: SB-649868 (DB14822)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-742457 35 mg/day
Trial: 12875613
Drug: donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: donepezil 10 mg/day
Trial: 15194366
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups received tacrolimus, mycophenolate mofetil, and steroids for maintenance immunosuppression
Trial: 15824681
Drug: High-dose epinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose epinephrine (HDE)
Trial: 15824681
Drug: Standard-dose epinephrine
RxNorm normalized name: epinephrine Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose epinephrine (SDE)
Trial: 1489123
Drug: Inhaled lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled lidocaine (20 mg and 80 mg from nebulized solutions)
Trial: 1489123
Drug: Citric acid
RxNorm normalized name: Citric Acid
DrugBank: Citric acid (DB04272)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citric acid (nebulized solutions 0.125 to 32%)
Trial: 3993874
Drug: Low-volume epidural
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-volume epidural morphine (2 mg in 1 ml saline) administered to Group II patients upon complaint of worst pain
Trial: 3993874
Drug: Low-volume epidural
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-volume epidural morphine (2 mg in 1 ml saline) administered to Group III patients after extubation but before pain complaint
Trial: 3993874
Drug: Standard volume
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard volume epidural morphine (2 mg in 10 ml saline) administered to Group I patients upon complaint of worst pain
Trial: 30985540
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (60 mg/kg)
Trial: 30985540
Drug: Saline (0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (0.9% saline, 100 ml)
Trial: 25316559
Drug: Garlic (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic (400 mg garlic and 1 mg allicin)
Trial: 23595874
Drug: 850 mg
RxNorm normalized name: bran 850 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 850 mg pure theobromine (TB)
Trial: 23595874
Drug: Cocoa intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa intervention (CC)
Trial: 23595874
Drug: Theobromine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theobromine and cocoa intervention (TB+CC)
Trial: 6669636
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg zopiclone
Trial: 25501294
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg zopiclone
Trial: 21694628
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g ethanol
Trial: 18269387
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg hyperbaric bupivacaine (B5C0)
Trial: 18269387
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg hyperbaric bupivacaine with 15 microg clonidine (B5C15)
Trial: 18269387
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg hyperbaric bupivacaine with 30 microg clonidine (B5C30)
Trial: 7506471
Drug: Human growth
RxNorm normalized name: Human growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human growth hormone (hGH) treatment (0.1 IU.kg‐1 body wt.day‐1 for 7 days)
Trial: 7506471
Drug: Human growth
RxNorm normalized name: Human growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human growth hormone (hGH) treatment
Trial: 29985440
Drug: Antiarrhythmic drug
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drug users (including digoxin and sotalol)
Trial: 29985440
Drug: Non-users of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-users of antiarrhythmic drugs
Trial: 24579970
Drug: Fasudil in
RxNorm normalized name: fasudil
DrugBank: Fasudil (DB08162)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Fasudil in addition to routine treatment
Trial: 18167382
Drug: Intravenous zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous zoledronic acid 5 mg
Trial: 18847584
Drug: Second dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second dose of misoprostol 800 mcg vaginally
Trial: 28103816
Drug: Self-assessment instrument
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-assessment instrument (Montgomery-Asberg Depression Rating Scale) used in recurrent consultations with GPs, treatment as usual (TAU) for 3 months, with at least 4 visits.
Trial: 28103816
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU) without the self-assessment instrument.
Trial: 21905158
Drug: Home-based physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based physical activity counseling (PA group, n = 20) for 3 months via telephone, including weekly PA tip sheets.
Trial: 21992075
Drug: Lapatinib plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib plus letrozole (L + Let)
Trial: 21992075
Drug: Letrozole monotherapy
RxNorm normalized name: Letrozole
DrugBank: Letrozole (DB01006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Letrozole monotherapy (Let)
Trial: 19090876
Drug: Chlorthalidone 12.5-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 12.5-25 mg/d
Trial: 19090876
Drug: Amlodipine 2.5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 2.5-10 mg/d
Trial: 19090876
Drug: Lisinopril 10-40
RxNorm normalized name: lisinopril 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 10-40 mg/d
Trial: 9032702
Drug: Glucose solution
RxNorm normalized name: TrueControl Glucose Solution Level 0
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose solution (0.1 kcal ml‐1)
Trial: 9032702
Drug: Milk protein
RxNorm normalized name: Milk protein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk protein (0.7 kcal ml‐1)
Trial: 9032702
Drug: Pea peptide
RxNorm normalized name: Pea
DrugBank: Pea (DB10551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pea peptide hydrolysate (0.2 kcal ml‐1)
Trial: 9032702
Drug: Whey peptide
RxNorm normalized name: Colostral Whey Peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey peptide hydrolysate (0.2 kcal ml‐1)
Trial: 7690583
Drug: 5-hydroxy-L-tryptophan (5-HTP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-hydroxy-L-tryptophan (5-HTP, 10 micrograms kg-1 min-1)
Trial: 7690583
Drug: gamma-L-glutamyl-5-hydroxy-L-tryptophan (glu-5-HTP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gamma-L-glutamyl-5-hydroxy-L-tryptophan (glu-5-HTP, 16.6 micrograms kg-1 min-1)
Trial: 3538367
Drug: 5-drug combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-drug combination therapy (vincristine, carmustine, alkylating agents, and prednisone)
Trial: 3538367
Drug: 2-drug combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-drug combination therapy
Trial: 2226737
Drug: 5-drug combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-drug combination therapy
Trial: 3538367
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy after remission
Trial: 3538367
Drug: Discontinued therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinued therapy after remission
Trial: 3538367
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy vs Discontinued therapy
Trial: 30092324
Drug: Dupilumab (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dupilumab (300 mg weekly for 16 weeks)
Trial: 27716697
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (MgSO4) 30 mg/kg in 500 cc normal saline
Trial: 27716697
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (500 cc normal saline)
Trial: 23230645
Drug: Fluoride gel
RxNorm normalized name: Sodium Fluoride Gel
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride gel (F) alone
Trial: 23230645
Drug: Fluoride gel
RxNorm normalized name: Sodium Fluoride Gel
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride gel (F) combined with chlorhexidine varnishes (CHX)
Trial: 27770695
Drug: Methadone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone treatment
Trial: 18402625
Drug: Daily dose
RxNorm normalized name: LENVIMA 8mg Daily Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dose (inpatients, mg) = 350.15 + 289.92 (desired lithium level, mmol/L) + 0.84 (weight, kg) - 1.76 (age, years) + 34.43 [TCA, yes = 1, no = 0] + 62.1(CL(Cr), L/h) + 13.1 [BUN, mmol/L] + 40.9 (sex, male = 1, female = 0)
Trial: 18402625
Drug: Daily dose
RxNorm normalized name: LENVIMA 8mg Daily Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dose (outpatients, mg) = 784.92 + 530.22 (desired lithium level, mmol/L) + 8.61 (weight, kg) - 12.09 (age, years) - 11.14 (TCA, yes = 1, no = 0) - 7.63 (CL(Cr), L/h) - 42.62 (BUN, mmol/L) - 23.43 (sex, male = 1, female = 0)
Trial: 15808751
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg of phVEGF-A(165)
Trial: 20009522
Drug: DTPa-HBV-IPV/Hib vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPa-HBV-IPV/Hib vaccine
Trial: 12424582
Drug: DTPa-IPV/Hib and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPa-IPV/Hib and HBV vaccines (comparator)
Trial: 12285561
Drug: 3 applications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 applications of 36 mg quinacrine hydrochloride pellets during the proliferative phase of 3 consecutive menstrual cycles
Trial: 6234966
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg rosoxacin by mouth (group B)
Trial: 6234966
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g spectinomycin administered intramuscularly (group A)
Trial: 24877116
Drug: Usual balance
RxNorm normalized name: Rebalance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual balance therapy
Trial: 20153389
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplements (LNS) mixed with porridge
Trial: 12225494
Drug: Parachute group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parachute group (intensive psychosocial treatment and support)
Trial: 7355429
Drug: Anticoagulant (AC)
RxNorm normalized name: CPDA-1 Anticoagulant
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anticoagulant (AC) treatment
Trial: 31056413
Drug: Anti-platelet therapy
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-platelet therapy
Trial: 31515418
Drug: Corneal cross-linking
RxNorm normalized name: riboflavin 5'-phosphate
DrugBank: Flavin mononucleotide (DB03247)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corneal cross-linking (CXL) treatment
Trial: 28766264
Drug: Acetaminophen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (20 mg/kg lean body mass)
Trial: 20619242
Drug: Losartan (angiotensin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (angiotensin II receptor blocker)
Trial: 17912637
Drug: Letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 2.5 mg daily for up to 5 years
Trial: 17912637
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg daily for up to 5 years
Trial: 12554545
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive therapy self-help program (n = 144)
Trial: 9522144
Drug: Tramadol 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 0.6 mg kg‐1
Trial: 9522144
Drug: Pethidine 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine 0.6 mg kg‐1
Trial: 9773840
Drug: Antenatal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal steroid administration
Trial: 27246567
Drug: Varenicline (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (0, 1, 2 mg/d)
Trial: 27246567
Drug: Varenicline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (1 and 2 mg/d)
Trial: 27246567
Drug: High-dose alcohol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose alcohol (0.08 g/dl)
Trial: 18840370
Drug: Capsule formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule formulation of meclofenoxate hydrochloride 200 mg
Trial: 18840370
Drug: Tablet formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet formulation of meclofenoxate hydrochloride 200 mg
Trial: 12818406
Drug: 15 ml
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml of linseed oil (rich in ALA) per day (n=50)
Trial: 12818406
Drug: 15 ml
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml of safflower oil (rich in LA) per day (n=26)
Trial: 11933306
Drug: Radiant heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiant heat therapy
Trial: 6240599
Drug: IK‐6‐Inhaletten (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IK‐6‐Inhaletten (0.1 mg Fenoterol + 0.04 mg Ipratropiumbromide)
Trial: 6240599
Drug: SCH 1000‐Inhaletten
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 1000‐Inhaletten (0.2 mg Ipratropiumbromide)
Trial: 27084301
Drug: Internet-based Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based Cognitive Behavioral Therapy (CBT)
Trial: 17573446
Drug: Roflumilast 500
RxNorm normalized name: ROFLUMILAST 500MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roflumilast 500 microg once daily for 4 weeks
Trial: 15670372
Drug: 5-fluorouracil-releasing microspheres
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil-releasing microspheres (130 mg) with early radiotherapy (59.4 Gy)
Trial: 15670372
Drug: 5-fluorouracil-releasing microspheres
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil-releasing microspheres (130 mg) with early radiotherapy (59.4 Gy) in patients with complete resection
Trial: 12191977
Drug: Warfarin (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (target INR of 1.4 to 1.9)
Trial: 29649425
Drug: 60 g freeze‐dried
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g freeze‐dried polyphenol‐rich whole grape powder (GP)
Trial: 29649425
Drug: 4 weeks
RxNorm normalized name: risperiDONE 75 mg/4 weeks intramuscular powder for injection, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 weeks of daily GP consumption
Trial: 28103829
Drug: Intravenous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration with three litres of Hartmann's solution between midnight and 8 am before kidney donation
Trial: 28103829
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no intravenous hydration)
Trial: 29452204
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antiviral therapy)
Trial: 26122235
Drug: Sustained virus
RxNorm normalized name: rubella virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained virus response to antiviral therapy
Trial: 26122235
Drug: No response
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No response to antiviral therapy
Trial: 23614999
Drug: BMS-663068 monotherapy
RxNorm normalized name: BMS dasatinib
DrugBank: Dasatinib (DB01254)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BMS-663068 monotherapy
Trial: 21923713
Drug: 10-day sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day sequential therapy (pantoprazole 40 mg + amoxicillin 1000 mg twice a day for 5 days, then pantoprazole 40 mg + clarithromycin 500 mg + metronidazole 500 mg twice a day for 5 days)
Trial: 21923713
Drug: 14-day PPI-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-day PPI-based triple therapy (pantoprazole 40 mg + amoxicillin 1000 mg + clarithromycin 500 mg twice a day for 14 days)
Trial: 16400951
Drug: Qingkailing soft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingkailing soft capsules (1.6 g, 4 times a day)
Trial: 16400951
Drug: Qingkailing soft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingkailing soft capsules
Trial: 31855680
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive (1.5 mg estradiol and 2.5 mg nomegestrolacetate)
Trial: 8749600
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive (COC)
Trial: 23989087
Drug: MIXED hemodiafiltration
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIXED hemodiafiltration at Qb 250 ml/min
Trial: 23989087
Drug: PRE hemodiafiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRE hemodiafiltration at Qb 250 ml/min
Trial: 23989087
Drug: MIXED hemodiafiltration
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIXED hemodiafiltration at Qb 300 ml/min
Trial: 23989087
Drug: PRE hemodiafiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRE hemodiafiltration at Qb 300 ml/min
Trial: 19419350
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline (HS) 4 ml/kg
Trial: 19419350
Drug: Hydroxyethyl starch
RxNorm normalized name: Hydroxyethyl starch
DrugBank: Hydroxyethyl Starch (DB09106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl starch (HES) 4 ml/kg
Trial: 16765146
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CC genotype)
Trial: 11688080
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement in the form of a fortified powder fruit drink, consumed 25 grams per school day for six months.
Trial: 9264076
Drug: Alcohol (0.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.25, 0.5, or 1.0 g/kg)
Trial: 8971287
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate 800 mg
Trial: 7888296
Drug: Ranitidine hydrochloride
RxNorm normalized name: Ranitidine Hydrochloride
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine hydrochloride 300 mg
Trial: 9657539
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg o.d.)
Trial: 3250317
Drug: Metoprolol CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol CR (100 mg o.d.)
Trial: 23564211
Drug: Cetirizine 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 15 mg + Verapamil 120 mg (P-gp blocker)
Trial: 23564211
Drug: Cetirizine 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 15 mg